Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep381 | Diabetes (pathiophysiology & epitemiology) | ECE2015

The correlation of serum ferritin and diabetes, glucose control or insulin resistance, related or not?

Li Jiang , Xiao Cheng , Cao Yongtong

Background: We have previously investigated the association between serum ferritin levels and risks of metabolic syndrome (MetS) using the same database from 2009 wave of the China Health and Nutrition Survey (2009 CHNS). We confirmed that MetS components are associated with increased serum ferritin levels in both men and women group, included abdominal obesity, hypertriglyceridemia, low HDL cholesterol, high blood pressure, and abnormal glucose level. Although, the prevalence...

ea0056p863 | Pituitary - Clinical | ECE2018

Interim results of a non-interventional, observational study evaluating the long-term safety and efficacy of pasireotide sc in Cushing’s disease

Giordano Carla , Schopohl Jochen , Yuen Kevin C J , Kriemler-Krahn Ulrike , Li Jiang , Maamari Ricardo , Manetti Luca

Introduction: Subcutaneous (sc) pasireotide effectively reduces cortisol levels, improves signs/symptoms and is generally well tolerated in Cushing’s disease (CD) patients, as shown in previous clinical trials. We report interim results from a multicentre, real-world observational study evaluating the long-term safety and efficacy of pasireotide sc in clinical practice in CD patients.Methods: Adults with CD, for whom surgery has failed or is not an ...